Switch to Raltegravir Decreases Soluble CD14 in Virologically Suppressed Overweight Women: The Women, Integrase, and Fat Accumulation Trial

OBJECTIVES: Soluble CD14 (sCD14) is a monocyte activation marker associated with increased mortality in HIV. We assessed 48-week changes in sCD14 and other inflammatory biomarkers in virologically suppressed, HIV-infected women switching to raltegravir (RAL) from PI or NNRTI. METHODS: HIV-infected w...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Lake, Jordan E., McComsey, Grace A., Hulgan, Todd, Wanke, Christine A., Mangili, Alexandra, Walmsley, Sharon L., Stramotas, Stephanie A., Tracy, Russell P., Currier, Judith S.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2014
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4107004/
https://ncbi.nlm.nih.gov/pubmed/24506429
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/hiv.12128
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller